ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

Similar documents
FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

HIV Drugs and the HIV Lifecycle

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

Drug Treatment Program Update

HIV medications HIV medication and schedule plan

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Antiretroviral Dosing in Renal Impairment

ANTIRETROVIRAL TREATMENTS (Part 1of

ADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute

Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services


HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

Nothing to disclose.

Antiretrovial Crushable/Liquid Formulation Chart

Medication Guide. October Contents. Preferred Medication List

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

HIV Infection & AIDS in Low- and Middle-Income Countries

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Appropriate Use & Safety Edits

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

Adherence Strategies for Older Adults. AIDS Community Research Initiative of America (ACRIA)

FLORIDA!A MEDICAID' Better Health Care for all Floridians. May

AIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION

Fluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search

treatment passport 1

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

Antiretroviral Pregnancy Registry

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

Section H: Treatments

Nobel /03/28. HIV virus and infected CD4+ T cells

Medication Errors Focus on the HIV-Infected Patient

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

MEDICATION RELATED ISSUES IN THE HIV PATIENT. LEONARD SOWAH, MBChB, MPH, FACP

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop

continuing education for pharmacists

Generic Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (2) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(3)

October 26-28: Training Day 1

Recommended comparator products: Medicines for HIV/AIDS and related diseases

The ART of Antiretroviral Therapy in Critically-ill Patients with HIV

A Fatal Imbalance. Tropical diseases: 18 new drugs (incl. 8 for malaria) 1.3% 21 new drugs for neglected diseases. Tuberculosis: 3 new drugs

HIV Management Update 2015

104 MMWR December 17, 2004

Approach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D.

Chapter 12. HIV Drug Glossary. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) *

World AIDS Day Year-by-Year Milestones in HIV/AIDS. healthlibrary

Medication Guide. July Contents. Click to search for a drug name in this document

May 2016 P & T Updates

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION

INDEX. indications...11 initiation of metabolic and morphologic complications

HIV / AIDS & Opportunistic Infections.

Health Insurance Marketplace 6 Tier Drug List

Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters

Genotyping and Drug Resistance in Clinical Practice. Case Studies

Medication Guide. January Contents

Addressing Pediatric Needs of the Most Neglected: next steps

Human Immunodeficiency Virus Infection A Modern Day Epidemic

Approach for the Newly Diagnosed HIV Positive Patient

PROGRESSIVE MULTI-FOCAL LEUKOENCEPHALOPATHY

NON-OCCUPATIONAL POST EXPOSURE PREVENTION. when you think you were exposed to hiv within the past three days

HIV Today: Examining the Latest Treatment Advances, Barriers to Care, and Pharmacists Implications

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 November 2010

Industry Data Request

P.I. Perspective. December 2008, Issue #47. Information, Inspiration and Advocacy for People Living with HIV/AIDS

Midwestern Underwriting Conference 2016

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012

30 Years of HIV: An Update on Treatment Guidelines and Beyond

Sculpting a Better Regimen: The ART of HIV Medications

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist

HIV in the United States: At A Glance

Selecting an Initial Antiretroviral Therapy (ART) Regimen

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

Gilead Sciences, LLC 50

Generic Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2)

Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos

Outline Epidemiology: Global and U.S. How are we doing in terms of goals of treatment? Updates in the fast moving field of HIV medicine EPIDEMIOLOGY

Bristol-Myers Squibb and Gilead Sciences, LLC 50

HIV/AIDS Update 2007

Review of predictive biomarkers in European Medicines Agency (EMA) drugs

The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project. ARV Dosing in End Stage Renal Disease

Comprehensive Guideline Summary

Objectives. HIV Treatment in Recently In 1996 the introduction of protease inhibitors decreasing the death rate of those infected by 50%.

Matters of the HAART: An Update on Current Treatment Options for HIV

The Hospitalized HIV+ Patient

HIV and YOU. Special 2008 Update!

Human Immunodeficiency Virus (HIV)

The New Agents: Management of Experienced Patients and Resistance. Joel E. Gallant, MD, MPH Johns Hopkins University School of Medicine

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

Transcription:

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA). Alabama ADAP Eligibility Criteria 1. Medical Eligibility Criteria = HIV diagnosis documented by lab test confirmation 2. Financial Criteria = Total Gross Household Income at or below 250% of the Federal Poverty Level (FPL) 3. Alabama Resident = (A PO Box is accepted to confirm a physical Alabama residence with other documentation to confirm client is a permanent Alabama resident) 4. No public or private third party payer source to provide the same service provided with Ryan White funds. 5. Remain compliant with ADAP Client Eligibility Reassessment (CER) 2x/year A 30-day supply of each medication is shipped each month on a regular schedule from the ADAP Central Pharmacy to the ordering Clinic for the Client or designee to pick up. ADAP/MEDCAP Prescriptions will be active for 12 months but all ADAP prescriptions only must be updated for each client on active and waiting ADAP during Client Eligibility Reassessment (CER) twice a year. This does NOT apply to MEDCAP enrollees for 2014. MEDCAP prescriptions for medications NOT on the formulary are to be written on the blank page (last page) of the Prescription Form - 2014 Generic formulations will be dispensed when available unless the Clinician specifically requests the Brand formulation when ordering a medication. ASAP shipment requests must be approved by the ADAP Coordinator based on the clinic s next regular scheduled medication shipment that is more than 7 working days from the date of the ASAP request. Pre-approval must be obtained from the ADAP Coordinator for any medications to be shipped to an alternate site. Permission for the ADAP Central Pharmacy to ship medications outside of the Clinic will be limited to a pre-approved Physician s order for home delivery due to a Client s poor medical condition limiting travel to the clinic for medication pick up. Medication Pre-approval is a requirement for several medications on the ADAP formulary. For assistance to complete pre-approval processes, please contact the ADAP Coordinator or an Eligibility Specialist at 1-866-574-996). Failure to pick-up ADAP medications for three (3) consecutive months will result in the Client s ADAP enrollment status being changed to Inactive due to non-compliance with medication adherence. Failure to complete Client Eligibility Reassessment (CER) will result in the Client s enrollment status made Inactive due to failure to complete the CER enrollment requirement. Clients in Inactive or Denied enrollment status may reapply to be considered for enrollment in ADAP at any time through a Social worker/case manager or Clinician to complete the ADAP application process. When there is an ADAP waiting list, approved applications are placed at the back of the waiting list and placed on active ADAP on a first-come-first-serve basis with no medical criteria.

PRESCRIPTION FORM 2014 Prescriptions fills x 12 *All ADAP prescriptions must be updated and resubmitted with Client Eligibility Reassessment (CER) Check One [ ] ADAP [ ] MEDCAP OFFICE USE ADAP ID# PATIENT NAME (Print) Last First DOB / / ARV s (34) Agenerase amprenavir Aptivus tipranavir Atripla efavirenz, emtricitabine, tenofovir Combivir zidovudine, lamivudine Complera emtricitabine, rilpivirine, tenofovir, disoproxil fumarate Crixivan indinivir sulfate Edurant rilpivirine Emtriva emtricitabine Epivir lamivudine Epzicom abacavir sulfate, lamivudine Fuzeon** enfuvirtide **PA** Intelence etravirine Invirase saquinavir mesylate Isentress raltegravir Kaletra lopinavir, ritonavir Lexiva fosamprenavir Norvir ritonavir Prezista daraunavir Rescriptor delavirdine mesylate Retrovir zidovudine Reyataz atazanavir sulfate Selzentry** maraviroc **PA** elvitegravir, cobicistat, Stribild emtricitabine, tenofovir disoproxil fumarate Sustiva efavirenz Trizivir abacavir, zidovudine, lamivudine Truvada tenofovir DF, emtricitabine Videx didanosine (buffered versions) didanosine Videx EC (delayed release capsules) Viracept nelfinavir sulfate Viramune nevirapine Viread tenofovir disoproxil fumarate DF Zerit stavudine Ziagen abacavir Check when requesting an ASAP shipment ASAP Request Approved [ ] Denied [ ] Date Initial Prescriber Name (Print) License # Prescriber (Signature) Date Prescriber Phone # Clinic Name Shipping Address City State ZIP Date to Pharmacy / / ES

PRESCRIPTION FORM 2014 Check One [ ] ADAP [ ] MEDCAP OFFICE USE ADAP ID# PATIENT NAME (Print) Last First DOB / / OI MEDICATIONS (29) Ancobon flucytosine Bactrim DS sulfamethoxazole/trimethoprim DS Biaxin clarithromycin Cleocin clindamycin Dapsone - Daraprim pyrimethamine Deltasone prednisone Diflucan fluconazole Famvir famciclovir Foscavir foscarnet Fungizone amphotericin B INH isoniazid Megace megestrol Mepron atovaquone Myambutol ethambutol Mycobutin rifabutin NebuPent pentamidine Probenecid - Procrit** epoetin alfa **PA** Pyrazinamide - (PZA) Sporonox itraconazole Sulfadiazine Oral Valcyte valganciclovir Valtrex valacyclovir VFEND voriconazole Vistide cidofovir Wellcovorin leucovorin Zithromax azithromycin Zovirax acyclovir - Check when requesting an ASAP shipment ASAP shipment Approved [ ] Denied [ ] Date Initial All ADAP prescriptions must be updated and resubmitted with Client Eligibility Reassessment (CER) every 6 months. Prescription refills x12 Prescriber Name (Print) License # Prescriber (Signature) Date Prescriber Phone # Clinic Name Shipping Address City State Zip Code Date to Pharmacy / / ES Initials

PRESCRIPTION 2014 Check One [ ] ADAP [ ] MEDCAP OFFICE USE ADAP ID# PATIENT NAME (Print) Last First DOB / / Medications listed under Other Medications may be removed from the formulary at any time to ensure that Alabama s ADAP continues to maintain adequate funding to provide Anti-HIV medications for enrollees; or in the event there is a need to re-instate the ADAP waiting list Other Medications (13) Baraclude entecavir Gardasil-IM - Havrix-IM hepatitis A virus Hepsera adedefovir Intron-A interferon alfa-2b Pegasys peg-interferon alfa-2a Peg-Intron peg-interferon alfa-2b Pneumovax pneumococcal 23-IM Rebetol ribavirin Rebetron ribavirin/interferon alfa-2b Recombivax hepatitis B virus HB-IM Roferon-A interferon alfa-2a Twinrix-IM hepatitis A and B virus PRE-APPROVAL REQUIREMENTS Fuzeon**PA** requires pre-approval prior to a prescription being processed by the ADAP Central Pharmacy. Call the ADAP Eligibility Office at 1-866-574-9964 or go to www.adph.org to access instructions and forms. Procrit**PA** requires pre-approval prior to a prescription being processed by the ADAP Central Pharmacy. Call the ADAP Eligibility Office at 1-866-574-9964 or go to www.adph.org to access pre-approval instructions and forms. Selzentry**PA** Tropism Assay testing required prior to a prescription being processed by the ADAP Pharmacy. Call the ADAP Eligibility Office at 1-866-574-9964 or go to www.adph.org to access Tropism Assay pre-approval instructions and forms. Check when requesting an ASAP shipment ASAP shipment Approved [ ] Denied [ ] Date Initials All ADAP prescriptions must be updated and resubmitted at Client Eligibility Reassessment (CER) every 6 months. Prescription refills x12 Prescriber Name (Print) License # Prescriber (Signature) Date Prescriber Phone # Clinic Name Shipping Address City State Zip Code Date to Pharmacy / / ES Initials

ADAP / MEDCAP PRESCRIPTION FORM 2014 ADAP Enrollees ADAP Formulary Medications Only Check One ADAP [ ] MEDCAP [ ] OFFICE USE ID# PATIENT NAME (Print) Last First DOB / / Order Medications NOT on the formulary on this prescription form for MEDCAP Enrollees Check when requesting an ASAP shipment ASAP shipment Approved [ ] Denied [ ] Date Initial There is no twice a year Client Eligibility Reassessment (CER) requirement for MEDCAP Prescription refills x12 for MEDCAP Complete this information Only when ordering a medication above. Prescriber Name (Print) License # Prescriber (Signature) Date Prescriber Phone # Clinic Name Shipping Address City State Zip Code Date to Pharmacy / / ES Initials